Neurophysiological assessment of the sedative and analgesic effects of a constant rate infusion of dexmedetomidine in the dog

Veterinary Journal

Volumn 190, Issue 3, 2011, Pages 338-344

  van Oostrom, Hugo ^a,c   Doornenbal, Arie ^a   Schot, Arend ^b   Stienen, Peter J ^a,c   Hellebrekers, Ludo J ^a,b,c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Analgesia; Dexmedetomidine; Dog; Evoked potential; Sedation

Indexed keywords

DEXMEDETOMIDINE; ANALGESIC AGENT;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFECT; EVOKED AUDITORY RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EXPERIMENTAL DOG; FEMALE; FUNCTIONAL ASSESSMENT; INFUSION RATE; LATENT PERIOD; MALE; MUSCULOSKELETAL SYSTEM PARAMETERS; NEUROPHYSIOLOGY; NONHUMAN; SEDATION; ANIMAL; BLOOD; DOG; DOSE RESPONSE; DRUG ADMINISTRATION;

CANIS FAMILIARIS;

ANALGESICS, NON-NARCOTIC; ANIMALS; DEXMEDETOMIDINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EVOKED POTENTIALS, AUDITORY; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; MALE;

EID: 84857211550     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.11.025     Document Type: Article

References (25)

1. Ansah O.B., Raekallio M., Vainio O. Correlation between serum concentrations following continuous intravenous infusion of dexmedetomidine or medetomidine in cats and their sedative and analgesic effects. Journal of Veterinary Pharmacology and Therapeutics 2000, 23:1-8.
2. Bergadano A., Andersen O.K., Arendt-Nielsen L., Schatzmann U., Spadavecchia C. Quantitative assessment of nociceptive processes in conscious dogs by use of the nociceptive withdrawal reflex. American Journal of Veterinary Research 2006, 67:882-889.
3. Beydoun A., Morrow T.J., Casey K.L. Pain-related laser-evoked potentials in awake monkeys: identification of components, behavioral correlates and drug effects. Pain 1997, 72:319-324.
4. Bol C.J., Vogelaar J.P., Mandema J.W. Anesthetic profile of dexmedetomidine identified by stimulus-response and continuous measurements in rats. The Journal of Pharmacology and Experimental Therapeutics 1999, 291:153-160.
5. Bromm B., Lorenz J. Neurophysiological evaluation of pain. Electroencephalography and Clinical Neurophysiology 1998, 107:227-253.
6. Davis H., Bowers C., Hirsh S.K. Relations of the human vertex potential to acoustic input: loudness and masking. Journal of the Acoustical Society of America 1968, 43:431-438.
7. Farber N.E., Poterack K.A., Schmeling W.T. Dexmedetomidine and halothane produce similar alterations in electroencephalographic and electromyographic activity in cats. Brain Research 1997, 774:131-141.
8. Franken N.D., van Oostrom H., Stienen P.J., Doornenbal A., Hellebrekers L.J. Evaluation of analgesic and sedative effects of continuous infusion of dexmedetomidine by measuring somatosensory- and auditory-evoked potentials in the rat. Veterinary Anaesthesia and Analgesia 2008, 35:424-431.
9. Haberham Z.L., van den Brom W.E., Venker-van Haagen A.J., de Groot H.N., Baumans V., Hellebrekers L.J. The rat vertex-middle latency auditory-evoked potential as indicator of anaesthetic depth: a comparison with evoked-reflex testing. Brain Research 2000, 873:287-290.
10. Hall J.E., Uhrich T.D., Barney J.A., Arain S.R., Ebert T.J. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesthesia and Analgesia 2000, 90:699-705.
11. Inui K., Tran T.D., Hoshiyama M., Kakigi R. Preferential stimulation of A delta fibers by intra-epidermal needle electrode in humans. Pain 2002, 96:247-252.
12. Inui K., Tran T.D., Qiu Y., Wang X., Hoshiyama M., Kakigi R. Pain-related magnetic fields evoked by intra-epidermal electrical stimulation in humans. Clinical Neurophysiology 2002, 113:298-304.
13. Jaakola M.L., Salonen M., Lehtinen R., Scheinin H. The analgesic action of dexmedetomidine - a novel alpha 2-adrenoceptor agonist-in healthy volunteers. Pain 1991, 46:281-285.
14. Katsarava Z., Ayzenberg I., Sack F., Limmroth V., Diener H.C., Kaube H. A novel method of eliciting pain-related potentials by transcutaneous electrical stimulation. Headache 2006, 46:1511-1517.
15. Kuusela E., Raekallio M., Anttila M., Falck I., Mölsä S., Vainio O. Clinical effects and pharmacokinetics of medetomidine and its enantiomers in dogs. Journal of Veterinary Pharmacology and Therapeutics 2000, 23:15-20.
16. Kuusela E., Vainio O., Kaistinen A., Kobylin S., Raekallio M. Sedative, analgesic, and cardiovascular effects of levomedetomidine alone and in combination with dexmedetomidine in dogs. American Journal of Veterinary Research 2001, 62:616-621.
17. Mantzaridis H., Kenny G.N. Auditory evoked potential index: a quantitative measure of changes in auditory evoked potentials during general anaesthesia. Anaesthesia 1997, 52:1030-1036.
18. Murrell J.C., de Groot H.N., Venker-van Haagen A.J., van den Brom W.E., Hellebrekers L.J. Middle-latency auditory-evoked potential in acepromazine-sedated dogs. Journal of Veterinary Internal Medicine 2004, 18:196-200.
19. Pascoe P.J., Raekallio M., Kuusela E., McKusick B., Granholm M. Changes in the minimum alveolar concentration of isoflurane and some cardiopulmonary measurements during three continuous infusion rates of dexmedetomidine in dogs. Veterinary Anaesthesia and Analgesia 2006, 33:97-103.
20. Pypendop B., Poncelet L., Verstegen J. Use of midlatency auditory-evoked potentials as indicator of unconsciousness in the dog: characterisation of the effects of acepromazine-thiopentone, medetomidine-thiopentone and medetomidine-butorphanol-midazolam combinations. Research in Veterinary Science 1999, 67:35-39.
21. Sinclair M.D. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice. The Canadian Veterinary Journal 2003, 44:885-897.
22. Stienen P.J., van Oostrom H., van den Bos R., de Groot H.N., Hellebrekers L.J. Vertex-recorded, rather than primary somatosensory cortex-recorded, somatosensory-evoked potentials signal unpleasantness of noxious stimuli in the rat. Brain Research Bulletin 2006, 70:203-212.
23. van Oostrom H., Stienen P.J., van den Bos R., de Groot H.N., Hellebrekers L.J. Somatosensory evoked potentials indicate increased unpleasantness of noxious stimuli in response to increasing stimulus intensities in the rat. Brain Research Bulletin 2007, 71:404-409.
24. van Oostrom H., Stienen P.J., Doornenbal A., Hellebrekers L.J. Nociception-related somatosensory evoked potentials in awake dogs recorded after intra epidermal electrical stimulation. European Journal of Pain 2009, 13:154-160.
25. Xu M., Kontinen V.K., Kalso E. Effects of radolmidine, a novel alpha2-adrenergic agonist compared with dexmedetomidine in different pain models in the rat. Anesthesiology 2000, 93:473-481.